BIOMARIN PHARMACEUTICAL INC (BMRN) /
The cash flow of BIOMARIN PHARMACEUTICAL INC over the past 10 years
Chart BIOMARIN PHARMACEUTICAL INC: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, BIOMARIN PHARMACEUTICAL INC's operating cash flow was $827.99M and its capital expenditures $103.04M, leaving free cash flow of $724.96M. Free cash flow was above zero in 5 of the 10 years shown. It ranged from -$376.22M in fiscal 2016 to $724.96M in fiscal 2025. Capital expenditures were highest in fiscal 2017, at $199.22M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $827.99M | $103.04M | $724.96M |
| 2024ended Dec 31, 2024 | $572.84M | $85.42M | $487.42M |
| 2023ended Dec 31, 2023 | $159.26M | $96.69M | $62.57M |
| 2022ended Dec 31, 2022 | $175.9M | $120.96M | $54.94M |
| 2021ended Dec 31, 2021 | $304.54M | $95.58M | $208.96M |
| 2020ended Dec 31, 2020 | $85.36M | $114.31M | -$28.95M |
| 2019ended Dec 31, 2019 | $48.26M | $145.03M | -$96.76M |
| 2018ended Dec 31, 2018 | $20.21M | $144.62M | -$124.41M |
| 2017ended Dec 31, 2017 | -$8.76M | $199.22M | -$207.98M |
| 2016ended Dec 31, 2016 | -$227.84M | $148.38M | -$376.22M |
Fiscal years as BIOMARIN PHARMACEUTICAL INC reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on BIOMARIN PHARMACEUTICAL INC
- The revenue of BIOMARIN PHARMACEUTICAL INC
- The profitability of BIOMARIN PHARMACEUTICAL INC
- The debt of BIOMARIN PHARMACEUTICAL INC
- All of BIOMARIN PHARMACEUTICAL INC's financials, charted
Companies of a similar size
Not investment advice. This page shows what BIOMARIN PHARMACEUTICAL INC filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.